Prostate cancer

. Prostate cancer is the third most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018).

. At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer.

. Localized prostate cancer can be asymptomatic at the early stage and often has an indolent course that may require only active surveillance.

. Indolent or aggressive, to treat or not to treat this cancer? This is always the question urologists ask themselves.

Prostate cancer incidence and mortality statistics worldwide in 2018

OncoDiag will be present at BIOTECHFINANCES Web-conferences (See Press releases) - September 24, 2020
OncoDiag at BioFIT 2020 - December 7 & 8, 2020 / Lille, FR
OncoDiag will present the Urodiag test (CE-IVD) at Updates in Oncourology (UDOU) - September 24 - 26, 2020 / Paris, FR